Volume 19, Number 12—December 2013
Research
Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011
Table 1
Neuraminidase inhibitor | Clade | No. | IC50 (nmol/L) |
Baseline‡ |
Mild outliers§ |
Extreme outliers¶ |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Min-Max | Median | Mean±SD† | No. | Min-Max | No. | IC50 | No. | IC50 | ||||||
Oseltamivir |
1.1 | 25 | 0.04–0.69 | 0.06 | 0.07 ± 0.02 | 23 | 0.04–0.16 | 1 | 0.52 | 1 | 0.69 | |||
2.3.2.1 | 70 | 0.13–527.26 | 0.41 | 0.43 ± 0.17 | 67 | 0.13–0.87 | 2 | 1.72–2.01 | 1 | 527.26 | ||||
2.3.4 | 28 | 0.51–11.36 | 1.62 | 1.48 ± 0.74 | 24 | 0.21–2.79 | 4 | 6.76–11.36 | 0 | NA | ||||
2.3.4/R** |
2 |
0.48–0.52 |
NA ‡‡ |
0.50 ± 0.10 |
2 |
0.48–0.52 |
0 |
NA |
0 |
NA |
||||
Zanamivir |
1.1 | 25 | 0.13–18.89 | 0.26 | 0.28 ± 0.10 | 23 | 0.13–0.54 | 1 | 1.33 | 1 | 18.89 | |||
2.3.2.1 | 70 | 0.14–1.11 | 0.32 | 0.34 ± 0.12 | 68 | 0.14–0.68 | 1 | 1.11 | 0 | NA | ||||
2.3.4 | 28 | 0.21–1.71 | 0.51 | 0.52 ± 0.18 | 27 | 0.21–0.99 | 1 | 1.71 | 0 | NA | ||||
2.3.4/R |
2 |
0.48–0.62 |
NA |
0.55 ± 0.07 |
2 |
0.48–0.62 |
0 |
NA |
0 |
NA |
||||
Peramivir | 1.1 | 25 | 0.07–0.31 | 0.13 | 0.14 ± 0.03 | 25 | 0.07–0.31 | 0 | NA | 0 | NA | |||
2.3.2.1 | 70 | 0.09–91.22 | 0.20 | 0.21 ± 0.09 | 69 | 0.09–0.47 | 0 | NA | 1 | 91.22 | ||||
2.3.4 | 28 | 0.16–0.52 | 0.29 | 0.31 ± 0.10 | 30 | 0.16–0.52 | 0 | NA | 0 | NA | ||||
2.3.4/R | 2 | 0.28–0.39 | NA | 0.33 ± 0.05 | 2 | 0.28–0.39 | 0 | NA | 0 | NA |
*IC 50, 50% inhibitory concentration; No., number of viruses analyzed; Min-Max, minimum to maximum of IC50 values; NA, not applicable; IQR, interquartile range.
†Mean and SD of IC50 values after exclusion of outliers.
‡ Viruses with IC50 values <U = Q3+3.0*(IQRIQR= Q3-Q1; Q1 = 25th percentile; Q3= 75th percentile.
§Mild outliers, with IC50 >U but <10-fold difference compared with the median IC50.
¶Extreme outliers, with IC50 >U and ≥10-fold difference compared with the median IC50.
**2.3.4/R,reassortants; the viruses belong to clade 2.3.4 but the neuraminidase genes are grouped with clade 2.3.2.1 (also see Technical Appendix, Table 2).
Page created: November 19, 2013
Page updated: November 19, 2013
Page reviewed: November 19, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.